Stress and Exposure Time on von Willebrand Factor Degradation

Despite the prevailing use of the continuous flow left ventricular assist devices (cf-LVAD), acquired von Willebrand syndrome (AvWS) associated with cf-LVAD still remains a major complication. As AvWS is known to be dependent on shear stress (τ) and exposure time (texp ), this study examined the degradation of high molecular weight multimers (HMWM) of von Willebrand factor (vWF) in terms of τ and texp . Two custom apparatus, i.e., capillary-tubing-type degrader (CTD) and Taylor-Couette-type degrader (TCD) were developed for short-term (0.033 sec ≤ texp  ≤ 1.05 s) and long-term (10 s ≤ texp  ≤ 10 min) shear exposures of vWF, respectively. Flow conditions indexed by Reynolds number (Re) for CTD were 14 ≤ Re ≤ 288 with corresponding laminar stress level of 52 ≤  τ CTD  ≤ 1042 dyne/cm2 . Flow conditions for TCD were 100 ≤ Re ≤ 2500 with corresponding rotor speed of 180 ≤ o  ≤ 4000 RPM and laminar stress level of 50 ≤  τ TCD  ≤ 1114 dyne/cm2 . Due to transitional and turbulent flows in TCD at Re > 1117, total stress (i.e., τ total  = laminar + turbulent) was also calculated using a computational fluid dynamics (CFD) solver, Converge CFD (Converge Science Inc., Madison, WI, USA). Inhibition of ADAMTS13 with different concentration of EDTA (5 mM and 10 mM) was also performed to investigate the mechanism of cleavage in terms of mechanical and enzymatic aspects. Degradation of HMWM with CTD was negligible at all given testing conditions. Although no degradation of HMWM was observed with TCD at Re < 1117 ( τ total  = 1012 dyne/cm2 ), increase in degradation of HMWM was observed beyond Re of 1117 for all given exposure times. At Re ~ 2500 ( τ total  = 3070 dyne/cm2 ) with texp  = 60 s, a severe degradation of HMWM (90.7 ± 3.8%, abnormal) was observed, and almost complete degradation of HMWM (96.1 ± 1.9%, abnormal) was observed with texp  = 600 s. The inhibition studies with 5 mM EDTA at Re ~ 2500 showed that loss of HMWM was negligible (<10%, normal) for all given exposure times except for texp  = 10 min (39.5 ± 22.3%, borderline-abnormal). With 10 mM EDTA, no degradation of HMWM was observed (11.1 ± 4.4%, normal) even for texp  = 10 min. This study investigated the effect of shear stress and exposure time on the HMWM of vWF in laminar and turbulent flows. The inhibition study by EDTA confirms that degradation of HMWM is initiated by shear-induced unfolding followed by enzymatic cleavage at given conditions. Determination of magnitude of each mechanism needs further investigation. It is also important to note that the degradation of vWF is highly dependent on turbulence regardless of the time exposed within our testing conditions.

[1]  Antoine Capel,et al.  The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves. , 2017, Journal of cardiothoracic and vascular anesthesia.

[2]  M. Strueber,et al.  von Willebrand factor disruption and continuous-flow circulatory devices. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  F. Beyersdorf,et al.  Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  Zhongjun J. Wu,et al.  Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor. , 2016, Artificial organs.

[5]  J. Moake,et al.  Acquired von Willebrand syndrome associated with left ventricular assist device. , 2016, Blood.

[6]  A. Undas,et al.  Increased bleeding risk in patients with aortic valvular stenosis: From new mechanisms to new therapies. , 2016, Thrombosis research.

[7]  Joachim O. Rädler,et al.  Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers. , 2015, Biophysical journal.

[8]  M. Acker,et al.  Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding. , 2015, JACC. Heart failure.

[9]  Peter Oshkai,et al.  The influence of the aortic root geometry on flow characteristics of a prosthetic heart valve. , 2015, Journal of biomechanical engineering.

[10]  M. Stark,et al.  Shear stress‐associated acquired von Willebrand syndrome in patients with mitral regurgitation , 2014, Journal of thrombosis and haemostasis : JTH.

[11]  Steven C Koenig,et al.  Insights into the mechanism(s) of von Willebrand factor degradation during mechanical circulatory support. , 2014, The Journal of thoracic and cardiovascular surgery.

[12]  A. Yoganathan,et al.  An In Vitro Evaluation of the Impact of Eccentric Deployment on Transcatheter Aortic Valve Hemodynamics , 2014, Annals of Biomedical Engineering.

[13]  Ranjit John,et al.  Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices , 2012, Circulation.

[14]  M. Seeberger,et al.  Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement. , 2012, British journal of anaesthesia.

[15]  C. Solomon,et al.  Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery. , 2011, British journal of anaesthesia.

[16]  Katharine H Fraser,et al.  The use of computational fluid dynamics in the development of ventricular assist devices. , 2011, Medical engineering & physics.

[17]  I. El-rassi,et al.  Treatment of Heyde’s Syndrome by Aortic Valve Replacement , 2011, Current cardiology reviews.

[18]  Dong Chen,et al.  Comparative Analysis of von Willebrand Factor Profiles in Pulsatile and Continuous Left Ventricular Assist Device Recipients , 2010, ASAIO journal.

[19]  F. Gräter,et al.  Shear‐induced unfolding activates von Willebrand factor A2 domain for proteolysis , 2009, Journal of thrombosis and haemostasis : JTH.

[20]  A Alexander-Katz,et al.  Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.

[21]  M. Yamaguchi,et al.  Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. , 2006, The Annals of thoracic surgery.

[22]  Gianluca Iaccarino,et al.  IMMERSED BOUNDARY METHODS , 2005 .

[23]  S. Susen,et al.  Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.

[24]  U. Windberger,et al.  Whole Blood Viscosity, Plasma Viscosity and Erythrocyte Aggregation in Nine Mammalian Species: Reference Values and Comparison of Data , 2003, Experimental physiology.

[25]  M. Hofbeck,et al.  Acquired von Willebrand syndrome in children with patent ductus arteriosus , 2002, Heart.

[26]  R. Nagel,et al.  Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. , 1994, Blood.

[27]  D. Coles Transition in circular Couette flow , 1965, Journal of Fluid Mechanics.

[28]  M. Acker,et al.  Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage. , 2015, The Journal of thoracic and cardiovascular surgery.